Clinical Trial Update: ONCOS-102 (Previously CGTG-102) for Therapy of Advanced Cancers [Phase 1]

View source ↗

Summary

Phase 1 trial of ONCOS-102 (formerly CGTG-102) in advanced malignant solid tumors has been completed, with results posted on 2014-10-02.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Malignant Solid Tumor

Drugs mentioned

• CGTG-102
• ONCOS-102

Snippet

Sponsor: Targovax Oy | Conditions: Malignant Solid Tumour | Phase 1 | Status: COMPLETED | Results posted: 2014-10-02